The thinking, in the room.
I speak and facilitate on the forces reshaping evidence and access, and on what it takes to lead through them. Keynotes, panel moderation, and executive workshops for conferences, leadership teams, and cross-functional groups that would rather work a hard question than hear a polished one.
What I am invited to address
The Three-Front Convergence
How innovation pressure, equity demands, and fiscal constraints are colliding on a single timeline, and what that collision asks of evidence strategy.
The Joint Clinical Assessment, in practice.
What Europe's first JCA cycle revealed about the operationalization gap, and how teams build evidence that holds when scope outruns it.
Real-world evidence that decisions can stand on
Designing real-world evidence to meet payer standards, grounded in work that helped pioneer real-world evidence for European regulatory authorization.
The business case for patient-focused drug development
Moving patient centricity from aspiration to an operating model: how building patient evidence into development differentiates an asset, makes a program more efficient and more likely to succeed, and produces value the market actually rewards.
Artificial intelligence as an operating advantage in evidence
Where generative and multi-agent methods genuinely change evidence workflows, and where senior judgment still has to govern the call.
And on leadership
Leadership through consequential transitions.
Drawing on twenty years of developing leaders and a coaching practice, I speak on how leaders navigate the inflection points that decide a career or a team, and on building the discernment to lead through them.
Three formats
Keynote
A prepared point of view that gives an audience something to argue with, not just applaud.
Panel moderation
I keep a panel honest, surfacing the genuine tensions in the question so the audience hears the real exchange, and reaching consensus where it is earned.
Executive workshop
A working session for a leadership or cross-functional team: we take the actual decision in front of you and work it through together.
Selected engagements
JCA, MFN, and the New Evidence Operating Model
Real World Wednesday, The RWD & RWE Podcast (hosts Aaron Kamauu and Matt Veatch)
Evidence strategy and reimbursement strategy
DIA Global Annual Meeting
"How Industry Pursues Internal and External Cross-Functional Collaborations During Drug Development to Optimize Market Access After Regulatory Approval."
ISPOR Educational Webinar Series
"The Proper Order of Things Is Often a Mystery: A Novel Approach to Selecting Treatment Sequences."
Real-world evidence
ACTRIMS and ECTRIMS forums
"Real-World Comparative Effectiveness and Treatment Decision Research in Multiple Sclerosis."
Patient-focused drug development
ISPOR Europe
"Patient-Focused Drug Development and Patient-Centered Clinical Care: Working Together."
Patients as Partners
"Engaging Internal Stakeholders to Embed Engagement in a Meaningful Way That Drives Value for Business and Patients."
eyeforpharma Patient Summit (USA)
"The Patient-Focused Drug Development Council Model for Carrying Patient Insight Through Development."
National Alliance for Caregiving / LEAD Coalition National Summit
"The Family Caregiver's Role in Patient-Focused Medical Product Development."
Leadership
Harvard T.H. Chan School of Public Health
Panelist, "Careers in Pharma: Leadership Trajectories and Community Building."
Bring this thinking to your stage or your team.
If you are shaping a conference program, a leadership offsite, or a cross-functional session and you want a voice that will move the conversation, I would welcome the invitation. Tell me the forum, the audience, and the question you want worked, and I will tell you whether I am the right person for it.
.png){kind=icon}
.avif)
Frequently Asked Questions
Evidence strategy and reimbursement strategy: the Three-Front Convergence, the EU Joint Clinical Assessment, real-world evidence, decision science, and the business case for patient-focused drug development, plus the role of artificial intelligence in evidence generation. I also speak on leadership through consequential transitions, drawing on my coaching practice.
Keynotes, panel moderation, and executive or cross-functional workshops. I shape each to the audience and the question rather than delivering a fixed talk.
Use the form here or the contact page. Tell me the forum, the audience, and the question you want addressed, and I will respond within two business days.
